Site icon Money & Markets, LLC

Picture This: Kodak Gets Lifeline, but Still Struggles

Eastman Kodak

When it came to camera film, Eastman Kodak Co. (NYSE: KODK) was the photography industry standard since before World War II.

The company was a mainstay in the world of print photography … at least until 2009.

That’s when Kodak stopped making its film due to the rise in digital photography … a 74-year run in the business.

The company filed for bankruptcy in 2012 as sales in its digital printing market dwindled.

Now, the company has received a lifeline by way of a $765 million grant from the U.S. government to expedite the production of generic drugs — including those to fight COVID-19.

The news sent Kodak stock surging 400% Wednesday, but gains like that aren’t sustainable in the long run.

Using Money & Markets Chief Investment Strategist Adam O’Dell’s stock rating system, we take a deeper dive into Eastman Kodak to see if the company is a buy for investors like you and me.

Kodak Is High on Value, but Low on Growth

While its shares jumped more than 440% on Wednesday, Adam’s system rates Kodak a 37 overall — 63% of all other stocks rate higher.

It rates high on value and momentum, but very low on growth and volatility.

Kodak Stock Makes a Big Move

Here’s what our analysis tells us:

What You Should Do Now About Eastman Kodak

Kodak’s grant from the government transforms the company 180 degrees.

However, it’s not enough to push the company to a winner.

As Adam’s system points out, weaker cash flow, high volatility and negative earnings per share make Kodak a company investors should steer clear of.

That could change if this change in direction yields fruit. But for now, it’s best to sit on the sidelines with Kodak.